Riv Capital Stock Price To Sales

CNPOF Stock  USD 0.08  0  4.88%   
RIV Capital fundamentals help investors to digest information that contributes to RIV Capital's financial success or failures. It also enables traders to predict the movement of RIV Pink Sheet. The fundamental analysis module provides a way to measure RIV Capital's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to RIV Capital pink sheet.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

RIV Capital Company Price To Sales Analysis

RIV Capital's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

P/S

 = 

MV Per Share

Revenue Per Share

More About Price To Sales | All Equity Analysis

Current RIV Capital Price To Sales

    
  7.93 X  
Most of RIV Capital's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, RIV Capital is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Competition

Based on the latest financial disclosure, RIV Capital has a Price To Sales of 7.9287 times. This is 62.95% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The price to sales for all United States stocks is 30.57% higher than that of the company.

Did you try this?

Run Sign In To Macroaxis Now

   

Sign In To Macroaxis

Sign in to explore Macroaxis' wealth optimization platform and fintech modules
All  Next Launch Module

RIV Fundamentals

About RIV Capital Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze RIV Capital's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of RIV Capital using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of RIV Capital based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in RIV Pink Sheet

RIV Capital financial ratios help investors to determine whether RIV Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in RIV with respect to the benefits of owning RIV Capital security.